FilingReader Intelligence
Hubei Biocause Pharmaceutical to voluntarily delist from exchange
August 8, 2025 at 03:10 PM UTC•By FilingReader AI
Hubei Biocause Pharmaceutical will voluntarily delist from the Shenzhen Stock Exchange following a shareholder vote scheduled for August 25, 2025.
The company will offer dissenting shareholders a cash option of 1.60 yuan per share through Jingmen Weituo Hongcheng Management Partnership. The stock will transfer to the NEEQ's delisting board.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Legal opinion on the termination of listing of Tianmao Industrial Group Co., Ltd. by Guohao Law Firm (Shanghai) (online)August 8, 2025 at 08:00 AM UTC
Hontop Industrial Group Company Limited's plan concerning the withdrawal of the company's shares from trading on the Shenzhen Stock Exchange (online publication)August 8, 2025 at 08:00 AM UTC
Special explanatory statement (online) from Tianmao Industrial Group Co., Ltd. regarding the protection of dissenting shareholdersAugust 8, 2025 at 08:00 AM UTC
Citic Securities Company Limited's financial advisory opinion regarding Tianmao Industrial Group Co., Ltd.'s voluntary termination of listing (online version)August 8, 2025 at 08:00 AM UTC
Announcement regarding the resumption of trading of the company's sharesAugust 8, 2025 at 08:00 AM UTC
Notice of convocation for the first extraordinary general meeting of shareholders in 2025August 8, 2025 at 08:00 AM UTC
Announcement on the revision of the articles of association and relevant rules of procedureAugust 8, 2025 at 08:00 AM UTC
Resolutions of the first 2025 special meeting of independent directors of the tenth board of directorsAugust 8, 2025 at 08:00 AM UTC
Announcement of resolutions from the fourth meeting of the tenth board of directorsAugust 8, 2025 at 08:00 AM UTC
Announcement by the board of directors regarding the public solicitation of voting rightsAugust 8, 2025 at 08:00 AM UTC
SZSE:000627•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Hubei Biocause Pharmaceutical publishes news
Free account required • Unsubscribe anytime